Literature DB >> 19737817

Toxoplasma gondii infection confers resistance against BimS-induced apoptosis by preventing the activation and mitochondrial targeting of pro-apoptotic Bax.

Diana Hippe1, Arnim Weber, Liying Zhou, Donald C Chang, Georg Häcker, Carsten G K Lüder.   

Abstract

In order to accomplish their life style, intracellular pathogens, including the apicomplexan Toxoplasma gondii, subvert the innate apoptotic response of infected host cells. However, the precise mechanisms of parasite interference with the mitochondrial apoptotic pathway remain unknown. Here, we used the conditional expression of the BH3-only protein Bim(S) to pinpoint the interaction of T. gondii with the intrinsic pathway of apoptosis. Infection of epithelial cells with T. gondii dose-dependently abrogated Bim(S)-triggered release of cytochrome c from host-cell mitochondria into the cytosol, induction of activity of caspases 3, 7 and 9, and chromatin condensation. Furthermore, inhibition of apoptosis in parasite-infected lymphocytes counteracted death of Toxoplasma-infected host cells. Although total cellular levels and mitochondrial targeting of Bim(S) was not altered by the infection, the activation of pro-apoptotic effector proteins Bax and Bak was strongly impaired. Inhibition of Bax and Bak activation by T. gondii was seen with regard to their conformational changes, the cytosol-to-mitochondria targeting and the oligomerization of Bax but not their cellular protein levels. Blockade of Bax and Bak activation was not mediated by the upregulation of anti-apoptotic Bcl-2-like proteins following infection. Further, the BH3-mimetic ABT-737 failed to overcome the Toxoplasma-imposed inhibition of Bim(S)-triggered apoptosis. These results indicate that T. gondii targets activation of pro-apoptotic Bax and Bak to inhibit the apoptogenic function of mitochondria and to increase host-cell viability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737817     DOI: 10.1242/jcs.050963

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  17 in total

1.  Infection of neutrophil granulocytes with Leishmania major activates ERK 1/2 and modulates multiple apoptotic pathways to inhibit apoptosis.

Authors:  Arup Sarkar; Eresso Aga; Uta Bussmeyer; Asima Bhattacharyya; Sonja Möller; Lars Hellberg; Martina Behnen; Werner Solbach; Tamás Laskay
Journal:  Med Microbiol Immunol       Date:  2012-06-03       Impact factor: 3.402

2.  Toxoplasma gondii ROP18: potential to manipulate host cell mitochondrial apoptosis.

Authors:  Liang Wu; Xiao Wang; Yunhui Li; Yuan Liu; Danhua Su; Tao Fu; Fei Guo; Liangping Gu; Xugan Jiang; Shengxia Chen; Jianping Cao
Journal:  Parasitol Res       Date:  2016-03-28       Impact factor: 2.289

Review 3.  A systems biological view of intracellular pathogens.

Authors:  Daniel P Beiting; David S Roos
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

4.  Toxoplasma gondii infection inhibits the mitochondrial apoptosis through induction of Bcl-2 and HSP70.

Authors:  Il-Young Hwang; Juan Hua Quan; Myoung-Hee Ahn; Hassan Ahmed Hassan Ahmed; Guang-Ho Cha; Dae-Whan Shin; Young-Ha Lee
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

5.  Toxoplasma gondii inhibits granzyme B-mediated apoptosis by the inhibition of granzyme B function in host cells.

Authors:  Tatsuya Yamada; Tadakimi Tomita; Louis M Weiss; Amos Orlofsky
Journal:  Int J Parasitol       Date:  2011-02-15       Impact factor: 3.981

6.  The Differential Effect of Toxoplasma Gondii Infection on the Stability of BCL2-Family Members Involves Multiple Activities.

Authors:  John Cherrington Carmen; Anthony Peter Sinai
Journal:  Front Microbiol       Date:  2011-01-24       Impact factor: 5.640

7.  A Fine Balance between Life and Death: Modulation of BCL-2 Family Members by Toxoplasma Gondii.

Authors:  Gustavo Arrizabalaga
Journal:  Front Microbiol       Date:  2011-03-07       Impact factor: 5.640

8.  Apoptosis-like cell death pathways in the unicellular parasite Toxoplasma gondii following treatment with apoptosis inducers and chemotherapeutic agents: a proof-of-concept study.

Authors:  Ayu Dewi Ni Nyoman; Carsten G K Lüder
Journal:  Apoptosis       Date:  2013-06       Impact factor: 4.677

9.  Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs.

Authors:  Sivasakthivel Thirugnanam; Namita Rout; Munirathinam Gnanasekar
Journal:  Infect Agent Cancer       Date:  2013-02-08       Impact factor: 2.965

10.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.